Skip to main content

Search

8 result(s) for 'author#Hoseah M. Akala' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. The ABO blood groups consist of A, B, and H carbohydrate antigens, which regulate protein activities during malaria infection in humans. Understanding the interplay between the malaria parasite and blood group...

    Authors: Redemptah Yeda, Charles Okudo, Eunice Owiti, Gladys Biwot, Cliff Momanyi, Winnie Korir, Thoya Mitsanze, Caroline Tegerei, Dennis Juma, Benjamin Opot, Edwin Mwakio, Gladys Chemwor, Raphael Okoth, Douglas O. Ochora, Agnes C. Cheruiyot, Amanda Roth…
    Citation: Malaria Journal 2022 21:251
  2. Sulphadoxine-pyrimethamine (SP), an antifolate, was replaced by artemether-lumefantrine as the first-line malaria drug treatment in Kenya in 2004 due to the wide spread of resistance. However, SP still remains...

    Authors: Dennis W Juma, Angela A Omondi, Luiser Ingasia, Benjamin Opot, Agnes Cheruiyot, Redemptah Yeda, Charles Okudo, Jelagat Cheruiyot, Peninnah Muiruri, Bidii Ngalah, Lorna J Chebon, Fredrick Eyase, Jacob Johnson, Wallace D Bulimo, Hoseah M Akala, Ben Andagalu…
    Citation: Malaria Journal 2014 13:250
  3. Dihydroartemisinin-piperaquine (DHA-PPQ) is an alternative first-line antimalarial to artemether-lumefantrine in Kenya. However, recent reports on the emergence of PPQ resistance in Southeast Asia threaten its...

    Authors: Dancan M. Wakoli, Bartholomew N. Ondigo, Douglas O. Ochora, Joseph G. Amwoma, Winnie Okore, Edwin W. Mwakio, Gladys Chemwor, Jackeline Juma, Raphael Okoth, Charles Okudo, Redemptah Yeda, Benjamin H. Opot, Agnes C. Cheruiyot, Dennis Juma, Amanda Roth, Benhards R. Ogutu…
    Citation: BMC Medicine 2022 20:448
  4. Malaria and schistosomiasis present considerable disease burden in tropical and sub-tropical areas and severity is worsened by co-infections in areas where both diseases are endemic. Although pathogenesis of t...

    Authors: Edwin Kamau, Adam Yates, Risper Maisiba, Valentine Singoei, Benjamin Opot, Rose Adeny, Cornel O. Arima, Victor Otieno, Catherine S. Sumbi, Raphael O. Okoth, Farid Abdi, Maurine Mwalo, Jew Ochola, June Otieno, Julie Ake, Michelle Imbach…
    Citation: BMC Infectious Diseases 2021 21:937
  5. Anti-malarial drug resistance in Kenya prompted two drug policy changes within a decade: sulphadoxine-pyrimethamine (SP) replaced chloroquine (CQ) as the first-line anti-malarial in 1998 and artemether-lumefan...

    Authors: Maroya D Spalding, Fredrick L Eyase, Hoseah M Akala, Sheryl A Bedno, Sean T Prigge, Rodney L Coldren, William J Moss and Norman C Waters
    Citation: Malaria Journal 2010 9:338
  6. Naturally acquired immunity (NAI), which is characterized by protection against overt clinical disease and high parasitaemia, is acquired with age and transmission intensity. The role of NAI on the efficacy of...

    Authors: Christine N. L. Wanjala, Elke Bergmann-Leitner, Hoseah M. Akala, Geoffrey Odhiambo, Bernhards R. Ogutu, Ben Andagalu, Edwin Kamau and Daniel Ochiel
    Citation: Malaria Journal 2020 19:168
  7. There are concerns that resistance to artemisinin-based combination therapy might emerge in Kenya and sub-Saharan Africa (SSA) in the same pattern as was with chloroquine and sulfadoxine–pyrimethamine. Single ...

    Authors: Peninah Muiruri, Denis W. Juma, Luicer A. Ingasia, Lorna J. Chebon, Benjamin Opot, Bidii S. Ngalah, Jelagat Cheruiyot, Ben Andagalu, Hoseah M. Akala, Venny C. S. Nyambati, Joseph K. Ng’ang’a and Edwin Kamau
    Citation: Malaria Journal 2018 17:398
  8. Vector-borne infections (VBI) are defined as infectious diseases transmitted by the bite or mechanical transfer of arthropod vectors. They constitute a significant proportion of the global infectious disease b...

    Authors: Mark M Fukuda, Terry A Klein, Tadeusz Kochel, Talia M Quandelacy, Bryan L Smith, Jeff Villinski, Delia Bethell, Stuart Tyner, Youry Se, Chanthap Lon, David Saunders, Jacob Johnson, Eric Wagar, Douglas Walsh, Matthew Kasper, Jose L Sanchez…
    Citation: BMC Public Health 2011 11(Suppl 2):S9

    This article is part of a Supplement: Volume 11 Supplement 2